Quantification of PD-L1 expression with 18F-BMS-986192 PET/CT in patients with advanced-stage non–small cell lung cancer
MC Huisman, ALN Niemeijer… - Journal of Nuclear …, 2020 - Soc Nuclear Med
The aim of this work was to quantify the uptake of 18F-BMS-986192, a programmed cell
death ligand 1 (PD-L1) adnectin PET tracer, in patients with non–small cell lung cancer. To …
death ligand 1 (PD-L1) adnectin PET tracer, in patients with non–small cell lung cancer. To …
Quantification of PD-L1 expression with F-18-BMS-986192 PET/CT in patients with advanced-stage non-small cell lung cancer
MC Huisman, ALN Niemeijer… - Journal of …, 2020 - scholarlypublications …
The aim of this work was to quantify the uptake of F-18-BMS-986192, a programmed cell
death ligand 1 (PD-L1) adnectin PET tracer, in patients with non-small cell lung cancer. To …
death ligand 1 (PD-L1) adnectin PET tracer, in patients with non-small cell lung cancer. To …
Quantification of PD-L1 expression with [18F] BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer
MC Huisman, ALN Niemeijer… - Journal of …, 2020 - researchinformation.amsterdamumc …
The aim of this work was to quantify the uptake of [18F] BMS-986192, a PD-L1 adnectin PET
tracer, in patients with non-small-cell lung cancer (NSCLC). To this end, plasma input kinetic …
tracer, in patients with non-small-cell lung cancer (NSCLC). To this end, plasma input kinetic …
[PDF][PDF] Quantification of PD-L1 Expression with 18F-BMS-986192 PET/CT in Patients with Advanced-Stage Non–Small Cell Lung Cancer
MC Huisman, ALN Niemeijer, AD Windhorst… - J Nucl …, 2020 - scholar.archive.org
The aim of this work was to quantify the uptake of 18F-BMS-986192, a programmed cell
death ligand 1 (PD-L1) adnectin PET tracer, in patients with non–small cell lung cancer. To …
death ligand 1 (PD-L1) adnectin PET tracer, in patients with non–small cell lung cancer. To …
Quantification of PD-L1 Expression with 18F-BMS-986192 PET/CT in Patients with Advanced-Stage Non-Small Cell Lung Cancer
MC Huisman, ALN Niemeijer… - Journal of nuclear …, 2020 - pubmed.ncbi.nlm.nih.gov
The aim of this work was to quantify the uptake of 18 F-BMS-986192, a programmed cell
death ligand 1 (PD-L1) adnectin PET tracer, in patients with non-small cell lung cancer. To …
death ligand 1 (PD-L1) adnectin PET tracer, in patients with non-small cell lung cancer. To …
Quantification of PD-L1 Expression with 18F-BMS-986192 PET/CT in Patients with Advanced-Stage Non-Small Cell Lung Cancer.
MC Huisman, AN Niemeijer, AD Windhorst… - Journal of Nuclear …, 2020 - europepmc.org
The aim of this work was to quantify the uptake of 18 F-BMS-986192, a programmed cell
death ligand 1 (PD-L1) adnectin PET tracer, in patients with non-small cell lung cancer. To …
death ligand 1 (PD-L1) adnectin PET tracer, in patients with non-small cell lung cancer. To …
[PDF][PDF] Quantification of PD-L1 Expression with 18F-BMS-986192 PET/CT in Patients with Advanced-Stage Non–Small Cell Lung Cancer
MC Huisman, ALN Niemeijer, AD Windhorst… - J Nucl …, 2020 - Soc Nuclear Med
The aim of this work was to quantify the uptake of 18F-BMS-986192, a programmed cell
death ligand 1 (PD-L1) adnectin PET tracer, in patients with non–small cell lung cancer. To …
death ligand 1 (PD-L1) adnectin PET tracer, in patients with non–small cell lung cancer. To …
[PDF][PDF] Quantification of PD-L1 Expression with 18F-BMS-986192 PET/CT in Patients with Advanced-Stage Non–Small Cell Lung Cancer
MC Huisman, ALN Niemeijer, AD Windhorst… - J Nucl …, 2020 - researchgate.net
The aim of this work was to quantify the uptake of 18F-BMS-986192, a programmed cell
death ligand 1 (PD-L1) adnectin PET tracer, in patients with non–small cell lung cancer. To …
death ligand 1 (PD-L1) adnectin PET tracer, in patients with non–small cell lung cancer. To …